Fecal Transplants in Kidney Recipients Reduced Resistant Pathogens

(MedPage Today) -- In the single-center PREMIX clinical trial, most renal transplant recipients were negative for multidrug-resistant pathogens shortly after receiving fecal microbiota transplants (FMT), with longer times to recurrent infections...
Source: MedPage Today Infectious Disease - Category: Infectious Diseases Source Type: news